Assessment of the pharmacokinetics of co-administered maraviroc and raltegravir

AIMS: To assess the two-way pharmacokinetic interaction between maraviroc and raltegravir. METHODS: In this open-label, multiple-dose, fixed-sequence study, 18 healthy, human immunodeficiency virus (HIV)-seronegative subjects received the following: days 1–3 raltegravir 400 mg q12h, days 4–5 washout...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Andrews, Emma, Glue, Paul, Fang, Juanzhi, Crownover, Penelope, Tressler, Randall, Damle, Bharat
Format: Artigo
Jezik:Inglês
Izdano: Blackwell Science Inc 2010
Teme:
Drug Interactions
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC2830597/
https://ncbi.nlm.nih.gov/pubmed/20078612
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2125.2009.03546.x
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki